Barker RA - Search Results

1

Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease.

Wijeyekoon RS, Kronenberg-Versteeg D, Scott KM, Hayat S, Kuan WL, Evans JR, Breen DP, Cummins G, Jones JL, Clatworthy MR, Floto RA, Barker RA, Williams-Gray CH. Wijeyekoon RS, et al. Among authors: barker ra. Brain Behav Immun. 2020 Jul;87:473-488. doi: 10.1016/j.bbi.2020.01.018. Epub 2020 Jan 30. Brain Behav Immun. 2020. PMID: 32006615 Free PMC article.

2

The heterogeneity of idiopathic Parkinson's disease.

Foltynie T, Brayne C, Barker RA. Foltynie T, et al. Among authors: barker ra. J Neurol. 2002 Feb;249(2):138-45. doi: 10.1007/pl00007856. J Neurol. 2002. PMID: 11985378 Review.

3

Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson's disease.

Michell AW, Luheshi LM, Barker RA. Michell AW, et al. Among authors: barker ra. Neurosci Lett. 2005 Jun 24;381(3):294-8. doi: 10.1016/j.neulet.2005.02.030. Epub 2005 Mar 2. Neurosci Lett. 2005. PMID: 15896487

4

No alterations in alpha-synuclein gene dosage observed in sporadic Parkinson's disease.

Williams-Gray CH, Goris A, Foltynie T, Brown J, Maranian M, Walton A, Compston DA, Sawcer SJ, Barker RA. Williams-Gray CH, et al. Among authors: barker ra. Mov Disord. 2006 May;21(5):731-2. doi: 10.1002/mds.20863. Mov Disord. 2006. PMID: 16552758 No abstract available.

5

Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.

Williams-Gray CH, Foltynie T, Lewis SJ, Barker RA. Williams-Gray CH, et al. Among authors: barker ra. CNS Drugs. 2006;20(6):477-505. doi: 10.2165/00023210-200620060-00004. CNS Drugs. 2006. PMID: 16734499 Review.

6

Increased capacity for axonal outgrowth using xenogenic tissue in vitro and in a rodent model of Parkinson's disease.

Kuan WL, Hurelbrink CB, Barker RA. Kuan WL, et al. Among authors: barker ra. Xenotransplantation. 2006 May;13(3):233-47. doi: 10.1111/j.1399-3089.2006.00291.x. Xenotransplantation. 2006. PMID: 16756566

7

The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias.

Kuan WL, Lin R, Tyers P, Barker RA. Kuan WL, et al. Among authors: barker ra. Neurobiol Dis. 2007 Mar;25(3):594-608. doi: 10.1016/j.nbd.2006.11.001. Epub 2006 Dec 22. Neurobiol Dis. 2007. PMID: 17188499

8

Visual hallucinations predict increased benefits from rivastigmine in Parkinson's disease dementia.

Williams-Gray CH, Barker RA. Williams-Gray CH, et al. Among authors: barker ra. Nat Clin Pract Neurol. 2007 May;3(5):250-1. doi: 10.1038/ncpneuro0471. Epub 2007 Mar 20. Nat Clin Pract Neurol. 2007. PMID: 17375057 No abstract available.

9

Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease.

Williams-Gray CH, Hampshire A, Robbins TW, Owen AM, Barker RA. Williams-Gray CH, et al. Among authors: barker ra. J Neurosci. 2007 May 2;27(18):4832-8. doi: 10.1523/JNEUROSCI.0774-07.2007. J Neurosci. 2007. PMID: 17475791 Free PMC article.

10

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.

Goris A, Williams-Gray CH, Clark GR, Foltynie T, Lewis SJ, Brown J, Ban M, Spillantini MG, Compston A, Burn DJ, Chinnery PF, Barker RA, Sawcer SJ. Goris A, et al. Among authors: barker ra. Ann Neurol. 2007 Aug;62(2):145-53. doi: 10.1002/ana.21192. Ann Neurol. 2007. PMID: 17683088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

645 results

Search Page

Filters